ARCHIVES

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

This article is from The Cancer Letter archive.

Vol. 03 No. 37 | September 17, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Cancer Control RFA Announcements

March 9, 1979

NIH Grantees Win Nobel Prizes In Medicine, Chemistry

October 9, 2009

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994

Cancer Control Awards $1 .5 Million Grant For 3-Year Study By College Of Radiology

April 26, 1974